BG
EXAS

Bollard Group’s Exact Sciences EXAS Stock Holding History

Bollard Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$102K – 312
2025
Q4 		$102K Hold
1,000
– – ﹤0.01% 206
2025
Q3 		$55K Buy
+1,000
New +$50K ﹤0.01% 206
2022
Q2 		– Sell
-733
Closed -$51K – 328
2022
Q1 		$51K Hold
733
– – ﹤0.01% 340
2021
Q4 		$57K Sell
733
-7,962
-92% -$703K ﹤0.01% 338
2021
Q3 		$830K Hold
8,695
– – 0.03% 144
2021
Q2 		$1.08M Hold
8,695
– – 0.03% 126
2021
Q1 		$1.15M Buy
8,695
+7,962
+1,086% +$1.09M 0.04% 119
2020
Q4 		$97K Hold
733
– – ﹤0.01% 272
2020
Q3 		$75K Hold
733
– – ﹤0.01% 283
2020
Q2 		$64K Buy
+733
New +$58.6K ﹤0.01% 311

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Bollard Group's EXAS Position: Q1 2026 in Review

Bollard Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,000 shares — an estimated $102K sold.

Bollard Group first reported a position in EXAS in Q2 2020 and held it in 10 quarters. The position peaked at $1.15M in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Bollard Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Bollard Group sold 1,000 Exact Sciences shares in Q1 2026, an estimated $102K.
  • Bollard Group first reported a position in Exact Sciences in Q2 2020 and held it in 10 quarters.
  • Bollard Group's Exact Sciences position peaked at $1.15M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Bollard Group's 13F filing for Q1 2026, filed 14 May 2026.